Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 12/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 2/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736067 | 0.89 | PRKCI (0.39) | PRKCIPIK3CAMEN1USP2TSHR | |
| SCHEMBL21735859 | 0.89 | HTR2C (0.36) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL21736126 | 0.88 | HTR2C (0.35) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL21736036 | 0.87 | GBA1 (0.39) | PRKCIPIK3CAMEN1USP2TSHR | |
| SCHEMBL17030461 | 0.87 | PRKCI (0.41) | PRKCIPIK3CAHRH4HTR2CMEN1 | |
| SCHEMBL20669905 | 0.87 | HTR2C (0.35) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL21735881 | 0.87 | HTR2C (0.35) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL21736061 | 0.86 | HTR2C (0.34) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL20670196 | 0.85 | KDM4E (0.36) | PRKCIPIK3CAHRH4HTR2CTNKS | |
| SCHEMBL17030451 | 0.84 | PIK3CA (0.39) | PRKCIPIK3CAHRH4HTR2CTNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| EP-3553049-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2022-01-19 | — | — | EP | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | PRKCI 4614/4885PIK3CA 4634/4885HRH4 2716/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | PRKCI 4614/4885PIK3CA 4634/4885HRH4 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.